Thirdly, Kawano discovered that “IL-6 is a growth factor for multiple myeloma cells.” In the absence of this discovery, the research project for tocilizumab could not be continued as it couldn’t overcome the barriers of the gap between production costs and drug price. The gene discussed is IL6; the disease is AL amyloidosis.